Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | HRAS |
Variant | G12R |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | HRAS G12R does not lie within any known functional domains of the Hras protein (UniProt.org). G12R results in decreased Hras GTPase activity and leads to transformation of cells in culture (PMID: 3042780, PMID: 6092966). |
Associated Drug Resistance | |
Category Variants Paths |
HRAS mutant HRAS act mut HRAS G12R HRAS mutant HRAS G12X HRAS G12R |
Transcript | NM_005343.4 |
gDNA | chr11:g.534289C>G |
cDNA | c.34G>C |
Protein | p.G12R |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001130442.2 | chr11:g.534289C>G | c.34G>C | p.G12R | RefSeq | GRCh38/hg38 |
NM_176795 | chr11:g.534289C>G | c.34G>C | p.G12R | RefSeq | GRCh38/hg38 |
NM_005343.3 | chr11:g.534289C>G | c.34G>C | p.G12R | RefSeq | GRCh38/hg38 |
NM_005343.4 | chr11:g.534289C>G | c.34G>C | p.G12R | RefSeq | GRCh38/hg38 |
NM_005343 | chr11:g.534289C>G | c.34G>C | p.G12R | RefSeq | GRCh38/hg38 |
NM_001130442.3 | chr11:g.534289C>G | c.34G>C | p.G12R | RefSeq | GRCh38/hg38 |
NM_176795.4 | chr11:g.534289C>G | c.34G>C | p.G12R | RefSeq | GRCh38/hg38 |
NM_176795.5 | chr11:g.534289C>G | c.34G>C | p.G12R | RefSeq | GRCh38/hg38 |
NM_001130442 | chr11:g.534289C>G | c.34G>C | p.G12R | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05638698 | Phase II | Balstilimab + QS21 + TG01 QS21 + TG01 | Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer (TESLA) | Active, not recruiting | USA | 0 |